0001125345-22-000049.txt : 20220517
0001125345-22-000049.hdr.sgml : 20220517
20220517172028
ACCESSION NUMBER: 0001125345-22-000049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220516
FILED AS OF DATE: 20220517
DATE AS OF CHANGE: 20220517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Koenig Scott
CENTRAL INDEX KEY: 0001587514
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36112
FILM NUMBER: 22935910
MAIL ADDRESS:
STREET 1: 9640 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MACROGENICS INC
CENTRAL INDEX KEY: 0001125345
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: Rockville
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-251-5172
MAIL ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
wf-form4_165282239043395.xml
FORM 4
X0306
4
2022-05-16
0
0001125345
MACROGENICS INC
MGNX
0001587514
Koenig Scott
9704 MEDICAL CENTER DRIVE
ROCKVILLE
MD
20850
1
1
0
0
President and CEO
Common Stock
2022-05-16
4
M
0
53265
1.51
A
1049636
D
Employee stock option (right to buy)
1.51
2022-05-16
4
M
0
53265
1.51
D
2023-01-05
Common Stock
53265.0
0
D
The transaction represents an exercise and hold of options. The shares are jointly owned with reporting person's spouse.
12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.
/s/ Lynn Cilinski, Attorney-in-Fact
2022-05-17